COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,710 Articles (22,913 medRxiv, 8,797 bioRxiv)

Most recent first Previous |  Page 1261: Articles 12601-12610  | Next

ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants
Seow, J., Graham, C., Hallett, S. R., Lechmere, T., Maguire, T. J. A., Huettner, I., Cox, D., Roberts, R., Waters, A., Ward, C. C., Mant, C., Pitcher, M. J., Spencer, J., Fox, J., Malim, M. H., Doores, K. J.
10.1101/2021.09.27.461862 — Posted: 2021-09-28
In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach.
Maes, M., Del Tedesco Junior, W. L., Lozovoy, M., Mori, M., Danelli, T., de Almeida, E., Tejo, A., Tano, Z., Reiche, E. M., Simao, A. N.
10.1101/2021.09.26.21264127 — Posted: 2021-09-28
Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein
Davis, J., Long, S. W., Christensen, P., Olsen, R. J., Olson, R., Shukla, M., Subedi, S., Stevens, R., Musser, J. M.
10.1101/2021.09.27.461949 — Posted: 2021-09-28
The BNT162b2 mRNA vaccine induces polyfunctional T cell responses with features of longevity.
Borsellino, G., Guerrera, G., Picozza, M., D'Orso, S., Placido, R., Pirronello, M., Verdiani, A., Termine, A., Fabrizio, C., Giannessi, F., Sambucci, M., Balice, M. P., Caltagirone, C., Salvia, A., Rossini, A., Battistini, L.
10.1101/2021.09.27.462006 — Posted: 2021-09-28
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
Schaffer, A. L., Henry, D., Zoega, H., Elliott, J., Pearson, S.-A.
10.1101/2021.09.26.21264150 — Posted: 2021-09-28
Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced Cambodians
Manning, J., Zaidi, I., Lon, C., Rosas, L. A., Park, J., Ponce, A., Bohl, J., Chea, S., Karkanitsa, M., Sreng, S., Rekol, H., Chour, C. M., Esposito, D., Taubenberger, J., Memoli, M., Sadtler, K. E., Duffy, P. E., Oliveira, F.
10.1101/2021.09.27.21264000 — Posted: 2021-09-28
Non-Pharmaceutical Interventions and COVID-19 Burden in the United States
Ahlers, M., Aralis, H., Tang, W., Sussman, J., Fonarow, G., Ziaeian, B.
10.1101/2021.09.26.21264142 — Posted: 2021-09-28
SARS-CoV-2 Transmission Potential and Policy Changes in South Carolina, February 2020 - January 2021
Davies, M. R., Hua, X., Jacobs, T. D., Wiggill, G. I., Lai, P.-Y., Du, Z., DebRoy, S., Robb, S. W., Chowell, G., Fung, I. C.-H.
10.1101/2021.09.25.21263798 — Posted: 2021-09-28
Modeling of COVID-19 Transmission Dynamics on US Population: Inter-transfer Infection in Age Groups, Mutant Variants, and Vaccination Strategies
Roy, J., Heath, S., Ramkrishna, D., Wang, S.
10.1101/2021.09.25.21264118 — Posted: 2021-09-28
Functional Data Analysis: Transition from Daily Observation of COVID-19 Prevalence in France to Functional Curves
Oshinubi, K., Ibrahim, F., Rachdi, M., Demongeot, J.
10.1101/2021.09.25.21264106 — Posted: 2021-09-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).